Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Longeveron Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −1 vs. Q4 2022
- Shares held
- 423.6K
- −26.2K (−5.8%) vs. Q4 2022
- Total value
- $1.13M
- −$316.8K (−21.9%) vs. Q4 2022
- New holders
- 1
- 6 more added
- Sold out
- 2
- 2 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LGVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $3.35M |
| Q1 2026 | 31 | $2.37M |
| Q4 2025 | 30 | $520.6K |
| Q3 2025 | 29 | $783.1K |
| Q2 2025 | 25 | $868.1K |
| Q1 2025 | 21 | $790.6K |
| Q4 2024 | 24 | $844.4K |
| Q3 2024 | 19 | $512.3K |
| Q2 2024 | 21 | $534.1K |
| Q1 2024 | 12 | $161.7K |
| Q4 2023 | 22 | $3.42M |
| Q3 2023 | 19 | $1.37M |
| Q2 2023 | 21 | $2.71M |
| Q1 2023 | 16 | $1.13M |
| Q4 2022 | 17 | $1.45M |
| Q3 2022 | 18 | $1.64M |
| Q2 2022 | 14 | $2.24M |
| Q1 2022 | 14 | $9.59M |
| Q4 2021 | 19 | $5.55M |
| Q3 2021 | 13 | $1.07M |
| Q2 2021 | 12 | $2.96M |
| Q1 2021 | 10 | $561.0K |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Longeveron Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 184,346 | $492.2K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 110,269 | $294.4K | 0.00% | +324+0.3% | Added |
| Geode Capital Management, LLC | 37,180 | $99.3K | 0.00% | 00.0% | Unchanged |
| Susquehanna Fundamental Investments, LLC | 24,992 | $66.7K | 0.00% | −442−1.7% | Reduced |
| State Street Corp | 14,800 | $39.5K | 0.00% | 00.0% | Unchanged |
| TownSquare Capital, LLC | 14,450 | $38.6K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 12,600 | $33.6K | 0.00% | +200+1.6% | Added |
| Northern Trust Corp | 10,623 | $28.4K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 4,874 | $13.0K | 0.00% | +4,864+48,640.0% | Added |
| UBS Group AG | 4,408 | $11.8K | 0.00% | +905+25.8% | Added |
| Advisor Group Holdings, Inc. | 2,000 | $5.34K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,029 | $5.00K | 0.00% | +1,038+104.7% | Added |
| Morgan Stanley | 700 | $1.87K | 0.00% | −3,919−84.8% | Reduced |
| The PNC Financial Services Group, Inc. | 220 | $587 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 38 | $101 | 0.00% | +1+2.7% | Added |
| Householder Group Estate & Retirement Specialist, LLC | 100 | $0 | 0.00% | +100 | New |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −23,511−100.0% | Sold out |
| Byrne Asset Management LLC | 0 | $0 | 0.00% | −5,800−100.0% | Sold out |